ジェノタイピング(遺伝子型判定)の世界市場:ポリメラーゼ連鎖反応(PCR)、DNAシークエンシング、マイクロアレイ、キャピラリー電気泳動

◆英語タイトル:Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020
◆商品コード:MAM-BT-3397
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2015年5月
◆ページ数:183
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD4,650 ⇒換算¥511,500見積依頼/購入/質問フォーム
Multi User (Five User)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD7,150 ⇒換算¥786,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、ジェノタイピング(遺伝子型判定)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、市場シェア分析、市場環境分析、技術別分析、用途別分析、製品別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms. The genotyping market is mainly driven by technological advancements, increasing incidence of genetic diseases and awareness on personalized medicine, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the growing demand for genotyping of animal and plant livestock. However, ambiguity in the reimbursement for these products and a lack of well-trained lab technicians are drivers expected to restrain the growth of this market in the forecast period.

The market in this report is broadly segmented based on products and services, technology, applications, and end users. The market, by technology, is segmented into microarrays, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others (in situ hybridization). Sequencing market is forecasted to grow at a highest CAGR 27.7% over the forecast period of 2015-2020, owing to its high speed, accuracy, flexibility, and increasing application areas.

Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

The global genotyping market is expected to grow at a CAGR of 22.3% during the forecast period of 2015 to 2020 to reach $17.0 billion in 2020. Genotyping tests are increasingly being used in drug discovery and development process and to provide personalized therapy, factors that are driving market growth. In addition to this, heavy investments by key manufacturers to offer advanced and innovative products for wider applications are also propelling market growth.

Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America). Emerging countries are expected to record strong growth. Growth will be centered on countries like India, China, and Brazil owing to rising investments by public and private players in these countries, improving healthcare infrastructure, increase in the number of clinical research organizations and clinical trials in these countries, and the focus of leading players to capture growth opportunities in these markets.

Some prominent players in this market include Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.). Various strategies such as collaborations, expansions, and new product launches helped these companies to maintain their market share and grow in this competitive market.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by top players in the genotyping market. The report analyzes the genotyping market by products and applications.
 Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the genotyping market.
 Market Development: Comprehensive information about lucrative emerging markets by product & services, technology, application, end user, and region.
 Market Diversification: Exhaustive information about new products, geographies, recent developments, and investments in the genotyping market.
 Competitive Assessment: In-depth assessment of market shares, growth strategies, products, manufacturing capabilities, and SWOT analyses of leading players in the genotyping market.

【レポートの目次】

1 Introduction (Page No. – 13)
1.1 Market Scope
1.1.1 Markets Covered
1.1.2 Years Considered for the Study
1.2 Currency & Pricing
1.3 Limitations
1.4 Stakeholders

2 Research Methodology (Page No. – 14)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 15)

4 Premium Insights (Page No. – 16)
4.1 Growth Potential of the Genotyping Market
4.2 Genotyping Market in the Asia-Pacific Region
4.3 Genotyping Market: Geographic Growth Opportunities
4.4 Geographic Mix: Genotyping Market, By Technology
4.5 Genotyping Market, By Application & Geography
4.6 Genotyping Market, By Geography

5 Market Overview (Page No. – 17)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Genotyping Market, By Product
5.2.2 Genotyping Market, By Technology
5.2.3 Genotyping Market, By Application
5.2.4 Genotyping Market, By End-User
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Advances in Technologies & Decreasing Prices of Dna Sequencing
5.3.1.2 Increasing Incidences and Awareness of Genetic Diseases and Personalized Medicine to Drive the Growth
5.3.1.3 Huge Demand From Emerging Economies With Their Expanding Per Capita Income
5.3.1.4 Growing Importance of Snp Genotyping in the Drug Development Process
5.3.1.5 Increasing Demand for Genome Analysis in Animal and Plant Livestock
5.3.2 Market Restraint
5.3.2.1 Lack of Appropriate Reimbursement Policies
5.3.2.2 Lack of Technical Know-How
5.3.3 Market Opportunity
5.3.3.1 Increasing Access to Healthcare & Growing Investment By Leading Players in Emerging Markets
5.3.3.2 Increasing Demand for Affordable Genotyping Services
5.3.3.3 Increasing Application Areas of Genotyping
5.3.4 Market Challenge
5.3.4.1 Increasing Market Consolidation

6 Industry Insights (Page No. – 21)
6.1 Introduction
6.2 Industry Trends
6.2.1 There is an Increasing Trend in the Pharmacogenomics Study
6.3 Porter’s Five Forces Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Strategic Benchmarking
6.4.1 Players Adopted New Product Launches as A Key Strategy to Increase Their Market Shares

7 Genotyping Market, By Product and Services (Page No. – 23)
7.1 Introduction
7.2 Instruments
7.2.1 Sequencers & Amplifiers
7.2.2 Analyzers
7.3 Reagents & Kits
7.4 Bioinformatics Software
7.5 Genotyping Services

8 Genotyping Market, By Technology (Page No. – 28)
8.1 Introduction
8.2 Microarray
8.3 Capillary Electrophoresis
8.3.1 Restriction Fragment Length Polymorphism (RFLP)
8.3.2 Amplified Fragment Length Polymorphisms (AFLP)
8.3.3 Single Strand Conformation Polymorphism (SSCP)
8.4 Sequencing
8.4.1 Next Generation Sequencing (NGS)
8.4.2 Sanger Sequencing
8.4.3 Pyrosequencing
8.5 Polymerase Chain Reaction (PCR)
8.5.1 Real Time PCR
8.5.2 Digital PCR
8.6 Maldi-Tof
8.7 Others

9 Genotyping Market, By Application (Page No. – 33)
9.1 Introduction
9.2 Pharmacogenomics
9.3 Diagnostic Research
9.4 Animal Genetics
9.5 Agricultural Biotechnology
9.6 Others

10 Genotyping Market, By End-User (Page No. – 39)
10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.3 Diagnostic & Research Laboratories
10.4 Academic Institutions

11 Genotyping Market, By Region (Page No. – 40)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (ROE)
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 46)
12.1 Overview
12.2 Market Share Analysis (2014)
12.3 Key Strategies Adopted By Leading Players
12.4 New Product Launches
12.5 Mergers and Acquisitions
12.6 Agreements, Partnerships, and Collaborations

13 Company Profiles (Page No. – 48)
13.1 Illumina, Inc
13.1.1 Business Overview
13.1.2 Product Portfolio
13.1.3 Key Strategy
13.1.4 Recent Developments
13.2 Affymetrix, Inc
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Key Strategy
13.2.4 Recent Developments
13.3 Life Technologies Corporation (Thermofisher Scientific)
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Key Strategy
13.3.4 Recent Developments
13.4 Agilent Technologies
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Key Strategy
13.4.4 Recent Developments
13.5 Qiagen NV
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Key Strategy
13.5.4 Recent Developments
13.6 Sequenom Inc.
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Key Strategy
13.6.4 Recent Developments
13.7 Fluidigm Corp.
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Key Strategy
13.7.4 Recent Developments
13.8 Beckman Coulter
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategy
13.8.4 Recent Developments
13.9 Roche
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategy
13.9.4 Recent Developments
13.10 GE Healthcare
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategy
13.10.4 Recent Developments

List of Tables (113 Tables)

Table 1 Global Genotyping Market Size, By Products and Services, 2012–2019 ($Million)
Table 2 Global Instruments Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 3 Global Sequencers Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 4 Global Analyzers Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 5 Global Reagents & Kits Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 6 Global Bioinformatics Software Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 7 Global Genotyping Services Market Size, By Country, 2012–2019 ($Million)
Table 8 Global Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 9 Global Microarray Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 10 Global Capillary Electrophoresis Market Size for Genotyping, By Type, 2012–2019 ($Million)
Table 11 Global Capillary Electrophoresis Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 12 Global RFLP Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 13 Global AFLP Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 14 Global SSCP Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 15 Global Sequencing Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 16 Global Sequencing Market Size for Genotyping, By Type, 2012–2019 ($Million)
Table 17 Global NGS Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 18 Global Sanger Sequencing Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 19 Global Pyrosequencing Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 20 Global Polymerase Chain Reaction (PCR) Market Size for Genotyping, By Type, 2012–2019 ($Million)
Table 21 Global Polymerase Chain Reaction (PCR) Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 22 Global Real Time PCR Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 23 Global Digital PCR Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 24 Global Maldi-Tof Market Size for Genotyping, By Country, 2012–2019 ($Million)
Table 25 Global Other Genotyping Technologies Market Size, By Country, 2012–2019 ($Million)
Table 26 Global Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 27 Global Genotyping Market Size for Pharmacogenomics, By Country, 2012–2019 ($Million)
Table 28 Global Genotyping Market Size for Diagnostic Research, By Country, 2012–2019 ($Million)
Table 29 Global Genotyping Market Size for Animal Genetics, By Country, 2012–2019 ($Million)
Table 30 Global Genotyping Market Size for Agricultural Biotechnology, By Country, 2012–2019 ($Million)
Table 31 Global Genotyping Market Size for Other Applications, By Country, 2012–2019 ($Million)
Table 32 Global Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 33 Global Genotyping Market Size for Pharmaceutical & Biopharmaceutical Companies, By Country, 2012–2019 ($Million)
Table 34 Global Genotyping Market Size for Diagnostic & Research Laboratories, By Country, 2012–2019 ($Million)
Table 35 Global Genotyping Market Size for Academic Institutes, By Country, 2012–2019 ($Million)
Table 36 Global Genotyping Market Size, By Region, 2012–2019 ($Million)
Table 37 Global Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 38 North America: Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 39 North America: Market Size, By Product & Services, 2012–2019 ($Million)
Table 40 North America: Market Size, By Technology, 2012–2019 ($Million)
Table 41 North America: Market Size, By Application, 2012–2019 ($Million)
Table 42 North America: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 43 U.S.: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 44 U.S.: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 45 U.S.: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 46 U.S.: Genotyping Market Size, End-User, 2012–2019 ($Million)
Table 47 Canada: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 48 Canada: Market Size, By Technology, 2012–2019 ($Million)
Table 49 Canada: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 50 Canada: Market Size, By End-User, 2012–2019 ($Million)
Table 51 Europe: Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 52 Europe: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 53 Europe: Market Size, By Technology, 2012–2019 ($Million)
Table 54 Europe: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 55 Europe: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 56 Germany: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 57 Germany: Market Size, By Technology, 2012–2019 ($Million)
Table 58 Germany: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 59 Germany: Market Size, By End-User, 2012–2019 ($Million)
Table 60 France: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 61 France: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 62 France: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 63 France: Market Size, By End-User, 2012–2019 ($Million)
Table 64 U.K.: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 65 U.K.: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 66 U.K.: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 67 U.K.: Market Size, By End-User, 2012–2019 ($Million)
Table 68 Italy: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 69 Italy: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 70 Italy: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 71 Italy: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 72 Spain: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 73 Spain: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 74 Spain: Market Size, By Application, 2012–2019 ($Million)
Table 75 Spain: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 76 ROE: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 77 ROE: Market Size, By Technology, 2012–2019 ($Million)
Table 78 ROE: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 79 ROE: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 80 Asia-Pacific: Genotyping Market Size, By Country, 2012–2019 ($Million)
Table 81 Asia-Pacific: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 82 Asia-Pacific: Market Size, By Technology, 2012–2019 ($Million)
Table 83 Asia-Pacific: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 84 Asia-Pacific: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 85 Japan: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 86 Japan: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 87 Japan: Market Size, By Application, 2012–2019 ($Million)
Table 88 Japan: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 89 China: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 90 China: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 91 China: Market Size, By Application, 2012–2019 ($Million)
Table 92 China: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 93 India: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 94 India: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 95 India: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 96 India: Market Size, By End-User, 2012–2019 ($Million)
Table 97 RoAPAC: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 98 RoAPAC: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 99 RoAPAC: Market Size, By Application, 2012–2019 ($Million)
Table 100 RoAPAC: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 101 RoW: Genotyping Market Size, By Country/Region, 2012–2019 ($Million)
Table 102 RoW: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 103 RoW: Market Size, By Technology, 2012–2019 ($Million)
Table 104 RoW: Genotyping Market Size, By Application, 2012–2019 ($Million)
Table 105 RoW: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 106 Latin America: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 107 Latin America: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 108 Latin America: Market Size, By Application, 2012–2019 ($Million)
Table 109 Latin America: Genotyping Market Size, By End-User, 2012–2019 ($Million)
Table 110 Middle East and Africa: Genotyping Market Size, By Product & Services, 2012–2019 ($Million)
Table 111 Middle East and Africa: Genotyping Market Size, By Technology, 2012–2019 ($Million)
Table 112 Middle East and Africa: Market Size, By Application, 2012–2019 ($Million)
Table 113 Middle East and Africa: Genotyping Market Size, By End-User, 2012–2019 ($Million)

List of Figures (37 Figures)

Figure 1 Global Genotyping Market
Figure 2 Research Methodology
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Genotyping Market Size, By Product, 2014 Vs.2019 ($ Million)
Figure 7 Global Genotyping Market Size, By Application, 2014 Vs.2019 ($ Million)
Figure 8 Geographical Snapshot of the Genotyping Market, 2014
Figure 9 High Growth in Asia-Pacific Market Provides Significant Opportunities for the Global Genotyping Market
Figure 10 at tractive Growth Opportunities in the Genotyping Market
Figure 11 U.S. to Command More Than One-Third of the Global Genotyping Market
Figure 12 North America to Account for the Largest Share of the Market During the Forecast Period
Figure 13 Genotyping Market, By Product
Figure 14 Genotyping Market, By Technology
Figure 15 Market, By Application
Figure 16 Market, By End-User
Figure 17 Drivers, Restraints, Opportunities & Threats for Genotyping Market
Figure 18 Increasing Pharmacogenomics Study
Figure 19 Porter’s Five Forces Analysis: Genotyping Products Manufacturing is A Capital-Intensive Industry
Figure 20 Strategic Benchmarking: New Product Launches, A Key Strategy Adopted By Leading Players
Figure 21 Reagents & Kits is the Fastest Growing Segment of Genotyping Market
Figure 22 Pharmacogenomics is the Fastest Growing Segment of Genotyping Market
Figure 23 Pharmaceutical & Biopharmaceutical is the Fastest Growing End-User of Genotyping Market
Figure 24 Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 25 Scenario in the Asia-Pacific Soft Tissue Repair Market, 2014
Figure 26 New Product Launches is the Key Growth Strategy Adopted By A Majority of the Leading Players
Figure 27 Global Soft Tissue Repair Market Share Analysis, By Key Player, 2014
Figure 28 Battle for Market Share: New Product Launches Was the Key Strategy
Figure 29 Geographic Revenue Mix of Key Players, 2014
Figure 30 Illumina, Inc. (Illumina): Company Snapshot
Figure 31 Affymetrix Inc.: Company Snapshot
Figure 32 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 33 Agilent Technologies, Inc.: Company Snapshot
Figure 34 Qiagen N.V.: Company Snapshot
Figure 35 Fluidigm Corporation: Company Snapshot
Figure 36 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 37 General Electric Company: Company Snapshot

【レポートのキーワード】

ジェノタイピング、遺伝子型決定、遺伝子型判定、ポリメラーゼ連鎖反応(PCR)、DNAシークエンシング、マイクロアレイ、キャピラリー電気泳動、MALDI_TOF、ジェノタイピング技術、ジェノタイピング装置、ジェノタイピング試薬、ジェノタイピングキット、バイオインフォマティクスソフトウェア、ジェノタイピングサービス

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[ジェノタイピング(遺伝子型判定)の世界市場:ポリメラーゼ連鎖反応(PCR)、DNAシークエンシング、マイクロアレイ、キャピラリー電気泳動]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月31日現在 190,554 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆